| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CELLDEX THERAPEUTICS INC NEW | 2,181,600 | 35,604,000 | 0.42% | ||
| 52 | BACTERIN INTL | 4,754,386 | 32,092,000 | 0.38% | ||
| 53 | DURATA THERAPEUTICS INC | 1,785,714 | 30,411,000 | 0.36% | ||
| 54 | EXACT SCIENCES CORP | 1,723,000 | 29,343,000 | 0.34% | ||
| 55 | ARRAY BIOPHARMA INC | 6,402,800 | 29,197,000 | 0.34% | ||
| 56 | INCYTE CORP SR NT CONV 4.750% 10/01/15 B/EDTD 03/30/10 0221 UBS FINANCIAL SERVICES INC. A/C MR06471 | 4,242,000 | 27,000,000 | 0.32% | PRN | |
| 57 | Medtronic Inc | 423,300 | 26,990,000 | 0.32% | ||
| 58 | XENOPORT INC | 5,546,100 | 26,788,000 | 0.31% | ||
| 59 | LILLY ELI & CO | 400,000 | 24,868,000 | 0.29% | ||
| 60 | MIRATI THERAPEUTICS INC COM | 1,172,000 | 23,440,000 | 0.28% | ||
| 61 | JAZZ PHARMACEUTICALS PLC | 150,000 | 22,052,000 | 0.26% | Call | |
| 62 | ALKERMES PLC | 433,300 | 21,808,000 | 0.26% | ||
| 63 | FLUIDIGM CORP DEL | 21,935,000 | 20,992,000 | 0.25% | PRN | |
| 64 | QIAGEN NV | 781,400 | 19,105,000 | 0.22% | ||
| 65 | CARDINAL HEALTH INC | 277,000 | 18,991,000 | 0.22% | ||
| 66 | NPS Pharmaceuticals, Inc. | 550,200 | 18,184,000 | 0.21% | ||
| 67 | CERUS CORP | 4,238,000 | 17,588,000 | 0.21% | ||
| 68 | VALEANT PHARMACEUTICALS INTL | 138,000 | 17,405,000 | 0.20% | ||
| 69 | JAZZ PHARMACEUTICALS PLC | 115,000 | 16,906,000 | 0.20% | ||
| 70 | FIVE PRIME THERAPEUTICS INC | 1,075,400 | 16,722,000 | 0.20% | ||
| 71 | COVIDIEN PLC | 180,600 | 16,287,000 | 0.19% | ||
| 72 | PUMA BIOTECHNOLOGY | 218,100 | 14,395,000 | 0.17% | ||
| 73 | MEI PHARMA INC | 1,924,500 | 12,201,000 | 0.14% | ||
| 74 | SYNAGEVA BIOPHARMA CORP | 111,100 | 11,643,000 | 0.14% | ||
| 75 | Questcor | 125,000 | 11,561,000 | 0.14% | ||
| 76 | Questcor | 125,000 | 11,561,000 | 0.14% | Put | |
| 77 | AGENUS INC | 3,586,100 | 11,547,000 | 0.14% | ||
| 78 | NXSTAGE MED INC COM | 795,200 | 11,427,000 | 0.13% | ||
| 79 | NUVASIVE INC | 316,000 | 11,240,000 | 0.13% | ||
| 80 | XOMA CORP DEL | 2,437,000 | 11,186,000 | 0.13% | ||
| 81 | INSMED INC | 538,500 | 10,759,000 | 0.13% | ||
| 82 | REDHILL BIOPHARMA LTD | 605,800 | 10,595,000 | 0.12% | ||
| 83 | MERGE HEALTHCARE INC | 4,628,500 | 10,507,000 | 0.12% | ||
| 84 | AMBIT BIOSCIENCES CORP | 1,490,769 | 10,301,000 | 0.12% | ||
| 85 | PERNIX THERAPEUTICS HLDGS IN | 1,130,600 | 10,153,000 | 0.12% | ||
| 86 | INSPIREMD INC | 3,395,000 | 10,015,000 | 0.12% | ||
| 87 | FOREST LABS INC COM | 97,000 | 9,603,000 | 0.11% | ||
| 88 | XENCOR INC COM | 801,700 | 9,316,000 | 0.11% | ||
| 89 | Questcor | 100,000 | 9,249,000 | 0.11% | Call | |
| 90 | SINOVAC BIOTECH LTD | 1,637,500 | 9,236,000 | 0.11% | ||
| 91 | ALIMERA SCIENCES INC | 1,500,000 | 8,970,000 | 0.11% | ||
| 92 | ArQule Inc | 5,702,000 | 8,838,000 | 0.10% | ||
| 93 | ST JUDE MED INC | 125,000 | 8,656,000 | 0.10% | Call | |
| 94 | HORIZON PHARMA PLC | 546,000 | 8,638,000 | 0.10% | ||
| 95 | Sunesis Pharmaceuticals I | 1,200,000 | 7,824,000 | 0.09% | ||
| 96 | ZOETIS INC | 229,000 | 7,390,000 | 0.09% | ||
| 97 | ABBOTT LABS | 180,000 | 7,362,000 | 0.09% | ||
| 98 | VANDA PHARMACEUTICALS INC COM | 455,000 | 7,362,000 | 0.09% | ||
| 99 | FLUIDIGM CORP DEL COM | 250,000 | 7,350,000 | 0.09% | Call | |
| 100 | AETNA INC NEW | 80,000 | 6,486,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-14-001491, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
